Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Clinical trial NCT03949049 · RECRUITING

Trial details

NCT number: NCT03949049
Sponsor: Sherief Abd-Elsalam
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neonatal Hypoxia

Start date: 2019-02-01
Primary completion: 2029-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.